Hello, I am new to the forum. My mom was diagnosed 8 years ago with a 1 cm lump and involvement in one lymph node. She had a mastectomy and underwent chemo. Went into complete remission until recent recurrence.
Now has spread to lung and bones, causing a fracture in her arm. She is refusing any additional treatment (she's 79). This is very scary for me, not knowing what to do - she lives 700 miles away and won't come to live near me or with me. I know without treatment it will be a downhill slide - and I have so many questions.
Anyone know a good resource for getting this type of question answered?
Here's an article from a great resouce, CURE magazine. It may not speak to your exact situation, but offers hope to those who are at Stage IV. Jackie, great to hear from you any time. Hugs, Lauri
www.curetoday.com/backissues/v2n3/features/expanding/index.html - 44k -
My mom has stage IV bc with mets to the bones and is HER2+. We were "thrilled" that the opinions from two oncologists concurred that mom's treatment plan didn't include chemo from the onset, rather that aromatase inhibitor therapy was quickly developing to be the best line of defense for metastasized bc in postmenopausal women. The benefit is that the side effects are much less severe - essentially induced osteoperosis (hence, the bone strengthener treatment). My mom's second opinion doctor at UCSF said that if the aromatase inhibitor therapy is successful, then it should keep being effective at keeping the cancer from spreading. He also eluded to research that will be making even more strides in the next few years.
My mother has been on Arimidex (anastrozole) daily and herceptin/bone strengthener every 3 weeks. In the first 2 weeks of taking Arimidex, her primary lump has reduced significantly in size. She has only had 1 herceptin/bone strengthener treatment which was quite painful for 48 hours.
My understanding of treating metastasized BC first with AIs/chemo/radiation vs. surgery is that the time it would take to recover from a lumpectomy/masectomy may be more risky than trying to shrink it all first. Here's a link to a March 2007 article from the National Cancer Institute re: the novelty of AIs.